HMGB1 and hepatocellular carcinoma: HMGB1 activates caspase-1 through RAGE/TLR4 signaling pathway in hypoxic HCC cells, leading to cleavage and release of proinflammatory cytokines such as IL-1β and IL-18, which in turn promotes the invasiveness and metastases of HCC [28].